How To Become A Millionaire - The Truth No One Tells You

how to become a millionaire
-its a goal
if you do what majority do you will get what majority gets

ff. the proper principles
1 there are no secrets on becoming a millionaire
-he is a boss and authority OVER HIMSELF
- be serious of yourself
0-RADICAL SELF GROWTH
-the reason why you are not a millionaire is your not resourceful enough
2 forget outer circumstances
- example lack of money,lack of education or skill\LIMITATIONS
YOU CANNOT BE A VICTIM AND MILLIONAIRE AT THE SAME TIME
-take full responsibility of yourself for all negative behavious you cannot make themn as your excuses
3 work hard within yourself
-right career with the right mindset can make you a millionaire\
4 MINDSET
-there is a thermostat win your brain on how much you earn subconsius thermostat level
-do internal work

-diff. mindset and philosophy take it seriously

5 Value education
-healthy empowering beliefs on money and success
- you have to make control
- your limiting belief can be a hindrance on being a millionaire
- you sub concious mind will drain your money if you have shitty beliefs
-dont think nbegative
6 make your own purpose
- fucos on what they can do in the world
- make some impact
- be a mo0tivation in and outside
- to0 have a motivation you need to have a deeper purpose
and money is not the reason***
- stop relying on peolple that will make you easy answer
-start on the inside
-money is insuficient for motivation
7you cant be a milliuonaireby just working hard
- become self employed a entrepreneur

class of millionare

* build a corporation
*one man shop(CELEB,DESIGNER)

8 THEY ARE TOO AFRAID TO LEAVE THE JOB
- there is no way you can beat your companies sucess
- know how you can make a transition
9 you can generate a lot of value in marketplace
- high value -high returns
- value=wealth
- know how to create value not just sell
IF YOU ARE SERIOUS ON BECOMING AMILLIONAIRE GO MAKE SOME PERSONAL GROWTH BE A MOTIVATIONLIVE IMPACT AND KNOW HOW TO CREATE VALUE

PUSH BOUNDARY CREATE MORE RESPONSIBILITY AND CREATE YOUR VALUE TO THE WORLD

Sad men: How men deal with sadness Women cry, grieve and then move on after a breakup. So why do broken-hearted men unravel in silence?

Dealing with a breakup
After she broke my heart, it was the little things that I remembered most: the way our mouths were a perfect fit, the way her face looked when she didn’t know I was watching her, the inexplicable, endearing things that would suddenly captivate her, like her favourite TV commercial. “Oh, I love this ad,” she would say every time it came on, and we watched it so many times that I swear every word, every gesture, every nuance of emotion of its 30-second story arc is tattooed forever upon my heart. 

The one thing that I couldn’t tell you is exactly what they were advertising—unless it was some fantasy about the nature of male heartache. Because, in this commercial, a young woman is at a wedding reception when she runs into her ex-boyfriend. He looks at her and melts—just melts. In his eyes—so full of wistful longing and regret—you can see that he knows exactly how much he has lost. And the young woman smiles—pretty, demure, spectacularly smug. “Love it to death,” my girlfriend would say. And I would bite my lip to avoid telling her “But male heartache looks nothing like that.”

Men's dark heartbreak
Outside of advertising, male heartache is a darker, more brooding beast. Rather than wearing its broken self on a sleeve, male heartache suffers in silence, grits its teeth and pretends that it doesn’t care. In real life, that brokenhearted hunk in the ad would have got drunk and tried to get off with the bridesmaid. And even back then, my heart was steeling itself because I knew that one day— after our love had been lost, betrayed or abandoned—my girlfriend and I would meet in some public place and she would be hoping for a remake of this ad.

Moving on after heartbreak
And so it proved. The set-up was the same, apart from the fact that we were in a Chinese restaurant, not at a wedding. But there she was, looking fabulous and sitting across from some dreamboat from central casting whom she couldn’t keep from kissing. Did I melt? Could you hear my heart breaking? As I sat there with my own new love, two tables down, did my eyes brim with loss and yearning? No, even though—between you and me—that was how I felt inside. I knew that this girl I had loved—and still did love— would spend the night in the arms of that other man.

Man Claims Parkinson’s Drug Turned Him Into a Gay Sex Addict

Didier Jambart, 51, of Nantes, France, began taking GlaxoSmithKline’s drug Requip (ropinirole) in 2003 to treat symptoms of Parkinson’s disease. Soon after, the married father of two began exhibiting strange, uncharacteristic behavior, his lawyers said.

(More on Time.com: 5 Little-Known Truths About American Sex Lives)

Agence France-Presse reports that Jambart:

…says he has attempted suicide three times, claims he became addicted to Internet gambling, losing the family’s savings and stealing to feed his habit.

He also became a compulsive gay sex addict and began exposing himself on the Internet and cross-dressing. His risky sexual encounters led to him being raped, his lawyers said.

The behaviour stopped when he stopped taking the drugs in 2005 but by then he had been demoted in his defence ministry job and was suffering from psychological trauma resulting from his addictions, his lawyers said.

It’s impossible that the drug made Jambart gay. But compulsive behaviors are a known side effect of ropinirole. A drug fact-sheet put together by the American Society of Health-System Pharmacists says that before taking ropinirole:

…you should know that some people who took medications such as ropinirole developed gambling problems or other intense urges or behaviors that were compulsive or unusual for them, such as increased sexual urges or behaviors. There is not enough information to tell whether the people developed these problems because they took the medication or for other reasons. Call your doctor if you have an urge to gamble that is difficult to control, you have intense urges, or you are unable to control your behavior.

However, Jambart’s attorneys said that this warning did not appear on drug inserts until 2006, after Jambart had discontinued the medication. (More on Time.com: A Brief History of Sex on TV)

The AFP reports that Jambart is seeking $610,000 in damages from Glaxo for selling a “defective” drug, and from his neurologist for failing to inform him properly about the drug. AFP also reports that GlaxoSmithKline declined to comment on the case.

Requip — which is also used to treat restless leg syndrome — is not the only drug associated with unusual behavioral side effects. Patients taking the sleep aid Ambien were found to engage in sleep-eating, sleepwalking, hallucinations, violent outbursts and even sleep-driving, according to a 2006 article in the New York Times.

Related Links:

Read more: http://healthland.time.com/2011/02/01/man-claims-glaxos-drug-made-him-a-gay-sex-addict/#ixzz25V5WChBL

medical guru: WHAT IS YOUNG ONSET PARKINSON'S DISEASE

medical guru: WHAT IS YOUNG ONSET PARKINSON'S DISEASE: WHAT IS PARKINSON'S DISEASE (PD)? Parkinson's disease is a chronic progressive neurological disease that affects a small area of nerve ...

WHAT IS YOUNG ONSET PARKINSON'S DISEASE

WHAT IS PARKINSON'S DISEASE (PD)?

Parkinson's disease is a chronic progressive neurological disease that affects a small area of nerve cells (neurons) in an area of the brain known as the substantia nigra. These cells normally produce dopamine, a chemical (neurotransmitter) that transmits signals between areas in the brain that, when working normally, coordinate smooth and balanced muscle movement. It is now known that there are other areas of the brain that can be involved which results in non-motor symptoms.

Parkinson's disease causes these nerve cells to die, and as a result, body movements and other functions are affected. We do not yet know what causes these cells to die. "Parkinsonism" is a term that is often used interchangeably with Parkinson's disease. Medically, Parkinsonism refers to any condition that causes symptoms similar to Parkinson's disease.

WHAT IS YOUNG ONSET PARKINSON'S DISEASE (YOPD)?

When someone who is 21-40 years old receives a diagnosis of Parkinson's disease, it is referred to as "young onset" Parkinson's disease. Although most symptoms are the same at whatever age PD develops, managing the disease can be particularly challenging for a younger person and the person's family   medically, psychologically and socially.

In general, young people tend to have a smoother course of the illness. Overall, the rate of the disease's progression is usually much slower in younger than older people, which may be due in part to the fact that younger people tend to have fewer general health problems. Associated problems such as memory loss, confusion and balance difficulties also tend to be less frequent in young people with the disease. However, young people often have more involuntary movement problems due to the most commonly prescribed PD medication, levodopa. For this reason, young onset patients are usually treated initially with alternatives to levodopa.

WHAT ARE THE PRIMARY MOTOR SYMPTOMS OF PARKINSON'S DISEASE?

• Tremor (when limb is at rest)
• Bradykinesia (slowness)
• Rigidity (stiffness)
• Postural instability (balance problems)

It is important to know that not all of these symptoms must be present for a diagnosis of Parkinson's disease to be considered. In fact, younger people may only notice one or two of these motor symptoms, especially in the early stages of the disease. Finally, not everyone with PD has a tremor, nor is a tremor proof positive of Parkinson's. If you suspect PD, see a neurologist or movement disorders specialist.

WHAT ARE SOME OF THE NON-MOTOR SYMPTOMS?

• Changes in mood, especially depression
• Sleep disorders
• Changes in thinking
• Problems with low blood pressure, bowel, bladder and sweating
• Skin changes

CAN I WORK IF I HAVE PARKINSON'S DISEASE?

It is not only possible to work with young onset Parkinson's disease, it is probable. Most people who were working prior to diagnosis continue to work for some period of time afterwards.

"How long will I be able to work?" This is usually the more difficult question to answer. The length of time each person continues working will depend on many different factors. Some will be related to the disease itself such as symptoms, medication side effects, or progression of the disease; others are likely to be environmental factors including the overall economy and your particular employer.  Learn More.

WHO GETS PARKINSON'S?

It is estimated that approximately 1.5 million Americans have Parkinson's disease. Men are slightly more likely to develop the disease than women, and approximately 60,000 new cases are diagnosed each year. Because the majority of people who get Parkinson's disease are over the age of 60, it has been (and continues to be) thought of as an "older person's" disease. Because of this, the disease is often overlooked in younger people, leading many to go undiagnosed or misdiagnosed for extended periods of time. In fact, about 10%-20% of those diagnosed with Parkinson's disease are under age 50, and about half of those are diagnosed before age 40.

IS IT GENETIC OR HEREDITARY?

The cause of Parkinson's disease is not yet known. However, Parkinson's disease has appeared across several generations of some families, which could indicate that certain forms of the disease are hereditary or genetic. Many researchers think that Parkinson's disease may be caused by genetic factors combined with other external factors. The field of genetics is playing an ever greater role in PD research, and scientists are continually working towards determining the cause or causes of PD.

IS THERE A CURE?

To date, there is no known cure or way to prevent Parkinson's disease. However, research is ongoing and remarkable progress is being made. There is very real hope that the causes, whether genetic, environmental, or some combination of the two, will soon be identified and the precise effects of these causes on brain function will be understood. Although there is no cure for the disease at this time, by identifying symptoms and determining a proper course of treatment, most people with the disease are able to remain active and lead fulfilling lives.

ARE THERE DOCTORS WHO SPECIALIZE IN PARKINSON'S DISEASE?

Doctors who are specially trained to diagnose and treat conditions of the brain and nervous system are called neurologists. Some neurologists have a subspecialty in movement disorders and work extensively with patients who have Parkinson's disease and other similar conditions.

HOW DO I FIND A PD SPECIALIST?

Larger hospitals or university systems often have movement disorders centers. If you do not live in or near a large city, you may have to travel further for an appointment. While not as convenient, you may find it worthwhile to work with a physician who deals exclusively with movement disorders. Often, once stabilized, in-person appointments are not required very frequently.

FDA Approves First Medication to Reduce HIV Risk

People diagnosed with HIV—the human immunodeficiency virus that without treatment develops into AIDS—take antiviral medications to control the infection that attacks their immune system.

Now, for the first time, adults who do not have HIV but are at risk of becoming infected can take a medication to reduce the risk of sexual transmission of the virus. The Food and Drug Administration (FDA) has approved the new use of Truvada—to be taken once daily and used in combination with safer sex practices—to reduce the risk of sexually acquired HIV-1 infection in adults who do not have HIV but are at high risk of becoming infected. (HIV-1 is the most common form of HIV.) In two large clinical trials, daily use of Truvada was shown to significantly reduce the risk of HIV infection by 42 percent in a study sponsored by the National Institutes of Health (NIH) of about 2,500 HIV-negative gay and bisexual men and transgender women, and by 75 percent in a study sponsored by the University of Washington of about 4,800 heterosexual couples in which one partner was HIV positive and the other was not. Debra Birnkrant, M.D., director of the Division of Antiviral Products at FDA, explains that Truvada works to prevent HIV from establishing itself and multiplying in the body. She notes that while this is a new approved use, Truvada is not a new product. It was approved by FDA in 2004 for use in combination with other medications to treat HIV-infected adults and children over 12 years old. “In the 80s and early 90s, HIV was viewed as a life-threatening disease; in some parts of the world it still is. Medical advances, along with the availability of close to 30 approved individual HIV drugs, have enabled us to treat it as a chronic disease most of the time,” Birnkrant says. “
But it is still better to prevent HIV than to treat a life-long infection of HIV,” she says.
Birnkrant stresses that Truvada is meant to be used as part of a comprehensive HIV prevention plan that includes consistent and correct condom use, risk reduction counseling, regular HIV testing, and treatment of any other sexually-transmitted infections. Truvada is not a substitute for safer sex practices, she says. back to top

  Person Must Be HIV Negative Truvada, produced by Gilead Sciences Inc., is a combination of two antiretroviral medications used to treat HIV—tenofovir disoproxil fumarate and emtricitabine. When Truvada is used as a treatment for HIV rather than a preventive, the patient also takes a third drug, Birnkrant says. Which of the other approved HIV drugs is added depends on the needs of the patient. Before this medicine is prescribed, Birnkrant says there are several factors that a person and his or her health care professional must consider in weighing the risk versus the benefit: The person must be tested to ensure that he or she is HIV negative. Flu-like symptoms—such as fever or muscle aches—are a red flag because they could indicate the presence of early, acute HIV infection, even if test results are negative. There is a window of four to five weeks with some tests, and up to three months with others, in which the antibodies that indicate HIV infection do not appear in the blood. Safety concerns tied to Truvada have to do with its effect on the bones and kidneys. While effects observed in clinical trials were mild and reversible with discontinuation of the medication, people with a history of bone or kidney ailments should be regularly monitored to ensure their continued health. It is recommended that the person also be tested for hepatitis B because worsening of hepatitis B infections has been reported in those who have both HIV-1 and hepatitis B when treatment with Truvada was stopped. back to top Infection Rates Unchanged To help prescribers and other health care professionals advise uninfected people considering taking Truvada, the medicine is being approved with a Risk Evaluation and Mitigation Strategy (REMS). The goals of the REMS are to inform prescribers and potential users of Truvada of the importance of taking the medication every day, the importance of regular HIV testing and the importance of using Truvada in combination with other measures known to reduce the risk of HIV infection. As part of the REMS, a voluntary training and education plan will be made available to potential prescribers. This program includes a medication guide and safety brochure for the prospective Truvada users that would detail the risks, recommended screening tests and key information to share with a health care professional. About 1.2 million Americans have HIV. The body’s immune system is devastated by AIDS, leaving those who have it vulnerable to deadly infections. Each year, about 50,000 adults and adolescents in the U.S. are newly diagnosed with HIV. The overall rate of HIV infection has remained stable at least since 2004. “The rates of new HIV infections have not significantly changed for a long time,” says Birnkrant. “From FDA’s standpoint, this is not acceptable for a serious disease.” This article appears on FDA's Consumer Updates page, which features the latest on all FDA-regulated products.

drug on hiv approved drugs by fda for hiv

smaller medium larger FDA Approves First Drug for HIV Prevention Truvada Approved for HIV-Negative People at High Risk of Infection By Daniel J. DeNoon WebMD Health News Latest HIV News FDA Approves First Drug for HIV Prevention Studies Show Value of AIDS Drugs as Prevention First Over-the-Counter HIV Test Approved Wednesday Is National HIV Testing Day Bacterial Vaginosis Increases Female-to-Male HIV Want More News? Sign Up for MedicineNet Newsletters! Reviewed by Louise Chang, MD July 16, 2012 -- The FDA has approved use of the HIV drug Truvada to help people at high risk avoid infection with the AIDS virus. Truvada is already approved as part of treatment regimens for people with HIV infection. But this is the first time the FDA has approved any drug for "pre-exposure prophylaxis" or PrEP -- that is, for protecting uninfected people against HIV. It is not a prescription to party, says Debra Birnkrant, MD, the FDA's director of antiviral products. "We stress that PrEP with Truvada must include safer-sex practices, counseling, and HIV testing," Birnkrant said at a news conference held to announce the decision. "Truvada should not be used alone for HIV prevention." Two major studies suggest that PrEP with Truvada may work as hoped: In the iPrEx study of 2,499 HIV-negative men and transgender women who have high-risk sex with men, those who took Truvada had 42% fewer HIV infections than those who did not. There was no evidence that taking Truvada increased unsafe sex, although study participants did not know for sure whether they were getting Truvada or an inactive placebo. The Partners PrEP study enrolled 4,758 heterosexual couples in which one member was infected with HIV and one was not. Truvada reduced the risk of HIV infection by 75%. In the real world, however, it is not at all clear whether people who take Truvada will also take more risks, such as having sex without condoms or having multiple sex partners. Moreover, Truvada must be taken every day in order to help prevent HIV infection. People in clinical trials did this. But if that doesn't happen in the real world, people who get infected while taking too few doses likely will end up with drug-resistant HIV infection that they can then spread to others. Reaction Mixed "The FDA's move today is negligence bordering the equivalence of malpractice, which will sadly result in new infections, drug resistance, and serious side effects among many, many people," Michael Weinstein, president of the AIDS Health Foundation, says in a news release. The AHF provides AIDS health care in 26 nations. Other AIDS groups feel differently. The Black AIDS Institute supports the use of PrEP, as does Fenway Health, a provider of health services to Boston's lesbian, gay, bisexual, and transgender community. "This approach can prevent many new infections and could dramatically impact HIV transmission worldwide as part of the tools we have available to stop the epidemic," Fenway medical director Kenneth H. Mayer, MD, says in a news release. Last May, an FDA advisory panel voted in favor of approving Truvada for PrEP. The panel voted overwhelmingly to approve PrEP for men who have sex with men and for uninfected partners of HIV-infected people. But the panel approved Truvada PrEP by only a 12-8 vote for others at risk of HIV infection.

Birnkrant noted that the FDA approval comes with a risk-reduction program. Doctors prescribing Truvada PrEP must ensure that patients test negative for HIV before taking the drug. New tests are advised every three months at least. In addition, people must be monitored for signs of kidney or bone problems -- which are among the long-term side effects sometimes seen with Truvada. And the FDA says it will stay in close touch with those prescribing and taking Truvada PrEP to fine-tune the risk-reduction program. "Education is the key," Birnkrant said. "We are committed to working with our public health colleagues to learn how best to use Truvada for PrEP so we can fully achieve the public health benefit it represents." Truvada costs about $1,100 a month. It's not yet clear whether Truvada PrEP will be covered by insurance. SOURCES: News conference, FDA, July 16, 2012. News release, Fenway Health. News release, AIDS Health Foundation. FDA web site. News release, Gilead. WebMD Health News: "FDA Panel OKs Truvada as First HIV-Preventive Drug." ©2012 WebMD, LLC. All Rights Reserved.